Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP545130.RAabm-TIb1oGGUS4u09zEOvVpIv7CVGD-So2ti06YzRMs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP545130.RAabm-TIb1oGGUS4u09zEOvVpIv7CVGD-So2ti06YzRMs130_assertion type Assertion NP545130.RAabm-TIb1oGGUS4u09zEOvVpIv7CVGD-So2ti06YzRMs130_head.
- NP545130.RAabm-TIb1oGGUS4u09zEOvVpIv7CVGD-So2ti06YzRMs130_assertion description "[MAL methylation status may therefore serve as a marker of platinum sensitivity while MAL protein may be a target for development of novel therapies aimed at enhancing sensitivity to platinum-based drugs in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP545130.RAabm-TIb1oGGUS4u09zEOvVpIv7CVGD-So2ti06YzRMs130_provenance.
- NP545130.RAabm-TIb1oGGUS4u09zEOvVpIv7CVGD-So2ti06YzRMs130_assertion evidence source_evidence_literature NP545130.RAabm-TIb1oGGUS4u09zEOvVpIv7CVGD-So2ti06YzRMs130_provenance.
- NP545130.RAabm-TIb1oGGUS4u09zEOvVpIv7CVGD-So2ti06YzRMs130_assertion SIO_000772 19642140 NP545130.RAabm-TIb1oGGUS4u09zEOvVpIv7CVGD-So2ti06YzRMs130_provenance.
- NP545130.RAabm-TIb1oGGUS4u09zEOvVpIv7CVGD-So2ti06YzRMs130_assertion wasDerivedFrom befree-20150227 NP545130.RAabm-TIb1oGGUS4u09zEOvVpIv7CVGD-So2ti06YzRMs130_provenance.
- NP545130.RAabm-TIb1oGGUS4u09zEOvVpIv7CVGD-So2ti06YzRMs130_assertion wasGeneratedBy ECO_0000203 NP545130.RAabm-TIb1oGGUS4u09zEOvVpIv7CVGD-So2ti06YzRMs130_provenance.